我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
2
2 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中(未招募)
100.0%
暂无批准数据
- Sound Wave Innovation and Sumitomo Heavy Industries announced a strategic alliance to manufacture and distribute the LIPUS-Brain transcranial low-intensity pulsed ultrasound therapeutic device for early-stage Alzheimer's disease patients. - The LIPUS-Brain device demonstrated high safety and efficacy in a 2022 exploratory clinical trial and became the first "Breakthrough Medical Device" designated by Japan's PMDA in September 2022. - The companies anticipate completing pivotal clinical trials by end of 2026 with medical device approval targeted for 2027, followed by nationwide expansion to medical institutions. - This minimally invasive ultrasound technology represents a potential breakthrough in addressing the growing global challenge of Alzheimer's disease and dementia treatment.